PE Fund Investments
Platinum Equity acquires 75% stake in pharma co. Inventia for $225-M: report
US-based buyout fund Platinum Equity has acquired a 75% stake in Mumbai-based pharmaceuticals company Inventia Healthcare at a valuation of INR 2,500 crore (USD 300 million),Existing PE investors - InvAscent Capital and Jacob Ballas - have exited their combined about 40% stake, while promoter Janak Shah and family have sold a part stake. Rothschild and Stifel Financial Corp advised the existing investors, while Barclays advised Platinum.
Between Jul-08 and Aug-20, Inventia had raised USD 34 M from Jacob Ballas and InvAscent.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
